Angiotensinogen antisense oligonucleotides and fluid intake

Clinical and Experimental Hypertension

Volumn 19, Issue 5-6, 1997, Pages 993-1007

  Sinnayah, P ^a   McKinley, M J ^a   Coghlan, J P ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin II; Angiotensinogen; Antisense oligonucleotide; Water Intake

Indexed keywords

ANGIOTENSINOGEN;

ANIMAL EXPERIMENT; CONFERENCE PAPER; FLUID INTAKE; GENE THERAPY; HORMONAL REGULATION; MALE; NERVE CELL NETWORK; NONHUMAN; OLIGONUCLEOTIDE PROBE; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; THIRST;

EID: 0030816353     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969709083201     Document Type: Conference Paper

References (41)

1. Bickerton, R.K., Buckley, J.P. Evidence for a central mechanism of angiotensin induced hypertension. Proc Soc Exp Biol Med. 106: 834-837, 1961.
2. Brosnihan, K.B., Diz, D.I., Schiavone, M.T., Averill, D.B., Ferrario, C.M. Approaches to establishing angiotensin II as a neurotransmitter. In Buckley, J.P., Ferrario, C.M. Brain Peptides and Catecholamines in Cardiovascular Regulation, Raven Press, New York, pp. 313-328, 1987.
3. Chiang, M.-Y., Chan, H., Zounes, M.A., Freier, S.M., Lima, W.F., Bennett, C.F. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J Biol Chem. 266, 18162-18171, 1991.
4. Chiasson, B.J., Hooper ,M.L., Murphy, P.R., Robertson, H.A. Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain. Eur J Pharmacol. 227: 451-453, 1992.
5. Clemens, D.L., Clauser, E., Celio, M.R., Inagami, I.T. Generation of angiotensinogen by cultural neuroblastoma and glioma cells. Brain Res. 364: 205-211, 1986.
6. Deschepper, C.F., Bouhnik, J., Ganong, W.F. Colocalization of angiotensinogen and glial fibrillary acidic protein in astrocytes in rat brain. Brain Res. 374: 195-198, 1986.
7. Epstein, A.N., Fitzsimons, J.T., Rolls, B.J. Drinking induced by injection of angiotensin into the brain of the rat. J Physiol. 210: 457-474, 1970.
8. Fernley, R.T., John, M., Niall, H.D., Coghlan, J.P. Purification and characterization of ovine angiotensinogen. Eur J Biochem. 154(3): 597-601, 1986.
9. Fitts, D.A. Angiotensin II receptors in SFO but not in OVLT mediate isoproterenol-induced thirst. Am J Physiol. 267 (I Pt 2): R7-R15, 1994.
10. Fitzsimons, J.T., Stricker, E M. Sodium Appetite and the renin-angiotensin system. Nature, New Biology. 231: 58-60, 1971.
11. Fregly, M.J., Rowland, N.E. Effect of DuP 753, a nonpeptide angiotensin II receptor antagonist, on the drinking responses to acutely administered dipsogenic agents in rats. P. S. E. B. M. 199: 158-164, 1992.
12. Gyurko, R., Weilbo, D., Phillips. M.I. Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul Pept. 49: 167-174, 1993.
13. Heidenreich, O., Kang, S.H., Xu, X., Nerenberg, M. Application of antisense technology to therapeutics. Molecular Medicine Today. 1: 128-133, 1995.
14. Hooper, M.L., Chiasson, B.J., Robertson, H.A. Infusion into the brain of an antisense oligonucleotide to the immediate-early gene c-fos suppresses production of Fos and produces a behavioral effect. Neurosci. 63: 917-924, 1994.
15. Hosutt, J. A., Rowland, N., Stricker, E.M. Hypotension and thirst in rats after isoproterenol treatment. Physiol Behav. 21(4): 593-598, 1978.
16. Houpt K., Epstein, A.N. The complete dependence of beta-adrenergic drinking on the renal dipsogen. Physiol Behav. 7: 897-902, 1971.
17. Joy, M.D., Lowe, R.D. Site of cardiovascular action of angiotensin n in the brain. Clin. Sciences. 39: 327-336, 1970.
18. Katovich, M.J., Barney, C.C., Fregly, M.J., McCaa, R.E. Effect of an angiotensin converting enzyme inhibitor (SQ 14,225) on betaadrenergic and angiotensin-induced thirsts. Eur J Pharmacol. 56: 123-130, 1979.
19. Leenen, F.H.H., Stricker, E.M., McDonald, R.H., De Jong, W. Relationship between increase in plasma renin activity and drinking following different types of dipsogenic stimuli. In Peters, G., Fitzsimons, J.T., Peters-Haefeli, L. Control Mechanisms of Drinking, Springer Verlag, Berlin, pp. 84-88, 1975.
20. Lind, R. W. Sites of action of angiotensin in the brain. In Harding J.W., Wright J.W., Speth, R.C., Barnes C.D. Angiotensin and blood pressure regulation. Academic Press, San Diego, pp. 135-163, 1988.
21. Lind, R. W., Swanson, L.W., Ganten, D. Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system. Neuroendocrinology. 40: 2-24, 1985.
22. Lynch, K.R., Hawelu-Johnson, C.L., Guyenet, P.G. Localization of brain angiotensinogen mRNA by hybridization histochemistry. Molecular Brain Res. 2: 149-158, 1987.
23. Mann, J.F.E., Johnson, A.K., Ganten, D. Plasma angiotensin II: Dipsogenic levels and angiotensin-generating capacity of renin. Am J Physiol. 238: R372-R377, 1980.
24. McKinley, M.J., Coghlan, J.P., Congiu, M., Denton, D.A, Fei, D.T., Park, R.G. Augmented plasma renin levels in dehydrated sheep with periventricular lesions. Brain Res. 376: 416-419, 1986.
25. McKinley, M.J., Rundgren, M., Coghlan, J.P. Cerebral osmoregulatory reduction of plasma renin concentration in sheep. Acta Physiol Scand. 152: 323-332, 1994.
26. Milligan, J.F., Matteucci, M.D., Martin, J.C. Current concepts in antisense drug design. J Medicinal Chem. 36(14): 1923-1937, 1993.
27. Ohkubo, H., Kageyama, R., Ujihara, M., Hirose, T., Inayama, S., Nakanishi S. Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc Natl Acad Sci U.S.A. 80: 2196-2200, 1983.
28. Paxinos, G., Watson, C. The Rat Brain in Stereotaxic Coordinates Academic, New York, 1982.
29. Pilowsky, P.M., Sazuki, S., Minson, J.B. Antisense oligonucleotides: a new tool in neuroscience. Clin Exper Pharmacol Physiol. 21: 935-944, 1994.
30. Robinson, M., Evered, M.D. Angiotensin and the arterial pressure in the control of thirst. In de Caro, G., Epstein, A.N. and Massi, M, The Physiology of Thirst, Plenum Press, New York, pp. 193-198, 1986.
31. Scammell, J.C., Fregly, M.J. Attenuation of isoproterenol-stimulated plasma renin activity by chronic estrogen treatment. Proc Soc Exp Biol Med. 167: 117-121, 1981.
32. Simpson, J.B. The circumventricular organs and the central actions of angiotensin. Neuroendocrinology. 32: 248-256, 1980.
33. Stein, C.A., Subasinghe. C., Shinozuka, K., Cohen, J.S. Physicochemical properties of phosphorothioate oligonucleotides. Nucl Acids Res. 16: 3209-3221, 1988.
34. Stornetta, R.L., Hawelu-Johnson, C.L., Guyenet, P.G., Lynch, K.R. Astrocytes synthesise angiotensinogen in brain. Science. 242: 1444-1446, 1988.
35. Stricker, E.M. The renin-angiotensin system and thirst: A reevaluation. II. Drinking elicited in rats by caval ligation or isoproterenol. J Comp Physiol Psychol. 91: 1220-1231, 1977.
36. Stull, R.A., Taylor, L.A., Szoka, J.C.Jr. Predicting antisense oligonucleotide inhibitory efficacy: A computational approach using histograms and thermodynamic indices. Nucl Acids Res. 20: 3501-3508, 1992.
37. Suzuki, S., Pilowsky, P., Minson, J., Arnolda, L., Smith, I.J.L., Chalmers, J. c-Fos antisense in rostral ventral medulla reduces arterial blood pressure. Am J Physiol. 266: R1418-1422, 1994.
38. Van Der Krol, A R., Mol, J.N.M., Stuitje A.R. Modulation of eukaryotic gene expression by complementary RNA or DNA sequences. Biotechniques. 6: 958-976, 1988.
39. Wahlstedt, D., Pic, H.E.M., Koob, G. M., Yee, F., Heilig, M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligonucleotides, Science. 259: 528-531, 1993.
40. Weilbo, D., Sernia, C., Gyurko, R., Phillips, I.M. Antisense inhibition of hypertension in the spontaneously hypertensive rat. Hypertension. 25: 314-319, 1995.
41. Zon, G. Brief overview of Genetic Expression by antisense oligonucleotides and In vivo applications. Molecular Neurobiology. 10(2-3): 219-22, 1995.